<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>164</number>
    <updateDate>2022-12-31T08:01:22Z</updateDate>
    <updateDateIncludingText>2022-12-31T08:01:22Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2021-02-02</introducedDate>
    <congress>117</congress>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Discharged from</name>
            <date>2021-03-03T22:48:43Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2021-02-02T20:10:12Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Lower Costs, More Cures Act of 2021</title>
        <congress>117</congress>
        <number>19</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2021-10-19</actionDate>
          <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Advancing Education on Biosimilars Act of 2021</title>
        <congress>117</congress>
        <number>1873</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2021-03-16</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2021-04-23</actionDate>
        <text>Became Public Law No: 117-8.</text>
        <type>President</type>
        <actionCode>E40000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-23</actionDate>
        <text>Became Public Law No: 117-8.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-23</actionDate>
        <text>Signed by President.</text>
        <type>President</type>
        <actionCode>E30000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-23</actionDate>
        <text>Signed by President.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-20</actionDate>
        <text>Presented to President.</text>
        <type>Floor</type>
        <actionCode>E20000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-20</actionDate>
        <text>Presented to President.</text>
        <type>President</type>
        <actionCode>28000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>17:51:54</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>17:51:53</actionTime>
        <text>On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101). (text: CR H1754)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>101</rollNumber>
            <url>https://clerk.house.gov/evs/2021/roll101.xml</url>
            <chamber>House</chamber>
            <congress>117</congress>
            <date>2021-04-14T21:51:53Z</date>
            <sessionNumber>1</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>17:51:53</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101).(text: CR H1754)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>101</rollNumber>
            <url>https://clerk.house.gov/evs/2021/roll101.xml</url>
            <chamber>House</chamber>
            <congress>117</congress>
            <date>2021-04-14T21:51:53Z</date>
            <sessionNumber>1</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>17:20:52</actionTime>
        <text>Considered as unfinished business. (consideration: CR H1783-1784)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>13:17:23</actionTime>
        <text>At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.</text>
        <type>Floor</type>
        <actionCode>H37220</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>13:11:22</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on S. 164.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>13:11:20</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H1754-1755)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-04-14</actionDate>
        <actionTime>13:10:54</actionTime>
        <text>Mr. Pallone moved to suspend the rules and pass the bill.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-03-08</actionDate>
        <actionTime>14:24:33</actionTime>
        <text>Held at the desk.</text>
        <type>Floor</type>
        <actionCode>H15000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-03-08</actionDate>
        <actionTime>14:16:24</actionTime>
        <text>Received in the House.</text>
        <type>Floor</type>
        <actionCode>H14000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-03-08</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2021-03-03</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Passed Senate without amendment by Unanimous Consent. (text: CR S1021)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2021-03-03</actionDate>
        <text>Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(text: CR S1021)</text>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-03-03</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021)</text>
        <type>Discharge</type>
      </item>
      <item>
        <actionDate>2021-03-03</actionDate>
        <text>Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S1021)</text>
        <type>Committee</type>
        <actionCode>14500</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2021-02-02</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2021-02-02</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>H001076</bioguideId>
        <fullName>Sen. Hassan, Margaret Wood [D-NH]</fullName>
        <firstName>Maggie</firstName>
        <lastName>Hassan</lastName>
        <party>D</party>
        <state>NH</state>
        <identifiers>
          <bioguideId>H001076</bioguideId>
        </identifiers>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>C001075</bioguideId>
        <fullName>Sen. Cassidy, Bill [R-LA]</fullName>
        <firstName>Bill</firstName>
        <lastName>Cassidy</lastName>
        <party>R</party>
        <state>LA</state>
        <identifiers>
          <bioguideId>C001075</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-02-02</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <laws>
      <item>
        <type>Public Law</type>
        <number>117-8</number>
      </item>
    </laws>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Health personnel</name>
        </item>
        <item>
          <name>Licensing and registrations</name>
        </item>
        <item>
          <name>Medical education</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2021-02-02</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2021-03-17T15:10:11Z</updateDate>
        <text>
          <![CDATA[ <p><b>Advancing Education on Biosimilars Act of 2021</b></p> <p>This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)<br> <br> The FDA may also maintain and operate a website to provide educational materials about biological products.</p>]]>
        </text>
      </summary>
      <summary>
        <versionCode>55</versionCode>
        <actionDate>2021-03-03</actionDate>
        <actionDesc>Passed Senate</actionDesc>
        <updateDate>2021-03-17T20:44:49Z</updateDate>
        <text>
          <![CDATA[ <p><b>Advancing Education on Biosimilars Act of 2021</b></p> <p>This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)<br> <br> The FDA may also maintain and operate a website to provide educational materials about biological products.</p>]]>
        </text>
      </summary>
      <summary>
        <versionCode>53</versionCode>
        <actionDate>2021-04-14</actionDate>
        <actionDesc>Passed House</actionDesc>
        <updateDate>2021-04-19T20:38:44Z</updateDate>
        <text>
          <![CDATA[ <p><b>Advancing Education on Biosimilars Act of 2021</b></p> <p>This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)<br> <br> The FDA may also maintain and operate a website to provide educational materials about biological products.</p>]]>
        </text>
      </summary>
      <summary>
        <versionCode>49</versionCode>
        <actionDate>2021-04-23</actionDate>
        <actionDesc>Public Law</actionDesc>
        <updateDate>2021-05-06T13:46:19Z</updateDate>
        <text>
          <![CDATA[ <p><b>Advancing Education on Biosimilars Act of 2021</b></p> <p>This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)<br> <br> The FDA may also maintain and operate a website to provide educational materials about biological products.</p>]]>
        </text>
      </summary>
    </summaries>
    <title>Advancing Education on Biosimilars Act of 2021</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Advancing Education on Biosimilars Act of 2021</title>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Advancing Education on Biosimilars Act of 2021</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Passed Senate</titleType>
        <title>Advancing Education on Biosimilars Act of 2021</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Engrossed in Senate</billTextVersionName>
        <billTextVersionCode>ES</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Enacted</titleType>
        <title>Advancing Education on Biosimilars Act of 2021</title>
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>Advancing Education on Biosimilars Act of 2021</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate</titleType>
        <title>Advancing Education on Biosimilars Act of 2021</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to educate health care providers and the public on biosimilar biological products, and for other purposes.</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Enrolled Bill</type>
        <date/>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117s164enr/xml/BILLS-117s164enr.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in Senate</type>
        <date>2021-03-03T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117s164es/xml/BILLS-117s164es.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2021-02-02T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117s164is/xml/BILLS-117s164is.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date>2021-04-24T03:59:59Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/PLAW-117publ8/xml/PLAW-117publ8.xml</url>
          </item>
        </formats>
        <type>Public Law</type>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2021-04-23</actionDate>
      <text>Became Public Law No: 117-8.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
